During the past decade, Atlanta ID group conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 17 clinical trials were completed, i.e. on average, 170% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Atlanta ID group" #1 sponsor was "Gilead Sciences" with 22 trials, followed by "Avexa" with 1 trials sponsored, "Bavarian Nordic" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Janssen Scientific Affairs, LLC" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Atlanta ID group" #1 collaborator was "Janssen Research & Development, LLC" with 1 trials as a collaborator and "National Institutes of Health (NIH)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Atlanta ID group" are "HIV Infections" (11 trials), "HIV-1 Infection" (9 trials), "Acquired Immunodeficiency Syndrome" (4 trials), "HIV" (4 trials) and "HIV-1-infection" (3 trials). Many other conditions were trialed in "Atlanta ID group" in a lesser frequency.

Most popular intervention types in "Atlanta ID group" are "Drug" (24 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "E/C/F/TAF" (4 trials), "FTC/RPV/TDF" (4 trials), "FTC/TDF" (4 trials), "B/F/TAF" (3 trials) and "E/C/F/TDF" (3 trials). Other intervention names were less common.

The vast majority of trials in "Atlanta ID group" are 26 trials for "All" genders.

Currently, there are NaN active trials in "Atlanta ID group". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Atlanta ID group, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Atlanta ID group, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".